Page last checked
Growth hormone-releasing hormone fragment (compounded preparation) · safety
Sermorelin side effects
The sermorelin side effects reported most often are anti-GHRH antibodies, rise in serum phosphate and injection-site pain. The full list is below, with the cited trial report cited at the bottom of the page.
Rarer, but worth being able to spot: allergic reaction and unknown long-term risk.
The sources describe these effects in relation to the dose and to the early weeks.
Sermorelin is the first 29 amino acids of the hormone that prompts growth hormone release. It is the shortest piece that still does the job at the pituitary. Anti-aging and wellness clinics sell it for energy, body composition and sleep.
None of that is what it was approved for. As Geref it was an American medicine for testing pituitary function and for growth failure in children. That product was withdrawn. The one adult study on this page ran 14 days and measured hormone levels, not how anyone looked or felt.
At a glance
Common reactions listed
5
Serious reactions listed
2
Boxed warning
No label exists
Strongest source
limited human data
Common reactions
The full list, as reported across the available trial evidence. There is no approved label to read frequency bands off, so these are the trials’ own figures.
| Reaction | Frequency |
|---|---|
| Anti-GHRH antibodies | Detected in 4 of 11 treated children at six months and 6 of 11 at twelve months; growth continued in the children who developed them |
| Rise in serum phosphate | Significant over 14 days of twice-daily dosing in older men, while fasting glucose, urinary C-peptide, blood pressure and blood counts were unchanged |
| Injection-site pain | Named in the review literature as a reported reaction; no incidence figure has been published for it |
| Short-term flushing, nausea, dizziness and headache | Named in the review literature as reported reactions; no incidence figure has been published for them |
| Transient prolactin rise | Described in the review literature as small and rapid; no incidence figure has been published |
Serious reactions to watch for
These are rarer, and they are the ones clinicians monitor for. Seek medical care if you have symptoms.
| Reaction | Frequency |
|---|---|
| Allergic reaction | Described as rare in the review literature — monitor |
| Unknown long-term risk | No long-term safety data exists. The pediatric trials ran a year, the adult study 14 days, and nothing longer has been published — monitor |
When to seek medical care
Each one below is a serious reaction from the table above, written as the signs you would actually notice. Spotting them is the job of this section; working out what they mean is a clinician’s.
Severe hypersensitivity reaction
Urgent1Read deeper
When these effects tend to occur
The cited evidence describes these effects in relation to the dose and to the early period of taking it, rather than as a constant background throughout.
When a study reports how side effects changed over time, it describes the group as a whole. It cannot predict one person’s experience.
Common questions
How long do sermorelin side effects last, and do they go away?
The sources do not commit to a set number of days. What they describe is a pattern — reactions cluster after you start and after each increase, then ease while the dose is held steady. Any page quoting an exact number of days is quoting something the sources do not say.
What are the most common sermorelin side effects?
Anti-GHRH antibodies, rise in serum phosphate, injection-site pain and short-term flushing, nausea, dizziness and headache — the table above has the rest, each with its frequency band and source.
Does sermorelin have a boxed warning?
No, because a boxed warning is part of an FDA-approved label and sermorelin has no approved label. That reflects what regulatory review has and has not covered, not a finding that serious risks were looked for and ruled out.
Can the sermorelin dose be lowered if side effects are hard to tolerate?
That decision belongs to the prescribing clinician. No approved schedule exists for this compound, so there is no labeled framework for adjusting a dose. That leaves the prescriber as the only place the decision can sit.
Does sermorelin cause hair loss?
Hair loss is not among the reactions listed on this page for sermorelin, because the cited trial report cited here does not carry it. Anything missing from the tables is outside what can be sourced here rather than ruled out, and a symptom that worries you belongs with a clinician.
Is fatigue a listed sermorelin side effect?
No — the cited trial report cited here does not list it. That describes what was reported, not proof that the symptom cannot happen.
Is constipation a listed sermorelin side effect?
Not separately. If a source groups stomach and gut events together, this page keeps that group intact. It does not invent named reactions the source never listed.
What should someone do about a serious sermorelin reaction?
Contact a clinician promptly, and emergency services if symptoms are severe or getting worse quickly. The section above describes what those reactions actually look like, so they can be spotted early rather than explained away.
Do the frequencies on this page mean the chance it happens to one person?
No. These figures describe groups in a study. A band shows how often a reaction appeared under that trial’s conditions. It cannot predict what will happen to one person.
Related
The schedule these reactions were recorded against, the comparisons, and the sourcing rules behind every grade on this page.
How strong the evidence is for sermorelin
Where sermorelin stands in tesamorelin vs sermorelin
How the sermorelin trials escalated to their top arm
Sermorelin concentration and dose-draw tool
Vial, water and dose for any peptide, with sermorelin as one example
Nausea weighed class-wide, including sermorelin
Primary regulatory documents, including sermorelin
All the pages sermorelin is compared with
Questions readers ask
Is it safe to take sermorelin?
What does sermorelin do to your face?
What to avoid while taking sermorelin?
How long can you stay on sermorelin?
- Lanes R, Carrillo E; Venezuelan Collaborative Study Group. Long-term therapy with a single daily subcutaneous dose of growth hormone releasing hormone (1-29) in prepubertal growth hormone deficient children. J Pediatr Endocrinol 1994;7(4):303-8retrieved 2026-08-12Human trial
- Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab 1992;75(2):530-5retrieved 2026-08-12Human trial
- Dominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, Ruchała M. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. Front Endocrinol 2026;17 — Table 1, sermorelin safety-signal rowretrieved 2026-08-12limited human data